CYP2C19 Genotyping to Guide Clopidogrel Prescribing for Neurovascular Indications: A Survey of Institutional Approaches. [PDF]
Stone RM +11 more
europepmc +1 more source
Decompensated heart failure after one year of successful therapy with mavacamten: a case report. [PDF]
Marchionni G +3 more
europepmc +1 more source
Cytochrome P450-Catalyzed Hydroxylation of Δ8-Tetrahydrocannabinol and Implications for Pharmacogenetics. [PDF]
Zhao M, Lazarus P.
europepmc +1 more source
Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease. [PDF]
Sun R, Du Y.
europepmc +1 more source
Predicting Chemotherapy Response in Triple-Negative Breast Cancer: The Role of CYP2Cs as a Biomarker and a Drug Target (A Proof-of-Concept Study). [PDF]
Zerouali N +11 more
europepmc +1 more source
Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics. [PDF]
Pjevac M, Bon J, Dolžan V.
europepmc +1 more source
PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD). [PDF]
Jin Y +11 more
europepmc +1 more source

